Device Trial Radar · NCT02617706
Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery
Last checked: Nov 20, 2026Latest source record: Aug 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jan 2017
Primary completion
Jan 2018
Study completion Jan 2019
Sponsor
- Lead sponsor
- Neogenix, LLC dba OgenixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).
Conditions
- Anorectal Surgeries
Interventions
EpifloDevice
Transdermal continuous oxygen therapy is oxygen delivery to the wound site directly. Ogenix makes a small portable oxygen concentrator (Trade Name: EPIFLO) that makes continuous transdermal delivery of oxygen possible. It is a 3 ounce oxygen generator that continuously delivers 3 ml of pure oxygen to the wound site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with surgical site infections measured with the Southampton Scoring System. The number of subjects with infection of the surgical site will be compared using chi-square or Fisher Exact test.Time frame: 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of General Surgery Allegheny General Hospital
Pittsburgh, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.